1. Ghasemi, Alaleh, Farazmand, Ali, Hassanzadeh, Vahideh, Jamshidi, Ahmadreza, Mahmoudi, Mahdi. 2022. Upregulation of KAT2B and ESCO2 gene expression level in patients with rheumatoid arthritis. In Clinical rheumatology, 42, 253-259. doi:10.1007/s10067-022-06351-4. https://pubmed.ncbi.nlm.nih.gov/36104638/
2. Hou, Yong-Sheng, Wang, Jing-Zhi, Shi, Shuai, Wang, Gui-Yu, Liu, Shu-Lin. . Identification of epigenetic factor KAT2B gene variants for possible roles in congenital heart diseases. In Bioscience reports, 40, . doi:10.1042/BSR20191779. https://pubmed.ncbi.nlm.nih.gov/32239175/
3. Zhang, Jieqiong, Hu, Zhenhua, Chung, Hwa Hwa, Tan, Ern Yu, Tee, Wee-Wei. 2023. Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. In Nature communications, 14, 2439. doi:10.1038/s41467-023-38132-1. https://pubmed.ncbi.nlm.nih.gov/37117180/
4. Ma, Wenbo, Zhang, Jinqiang, Chen, Weina, Liu, Nianli, Wu, Tong. 2024. The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling. In Journal of experimental & clinical cancer research : CR, 43, 117. doi:10.1186/s13046-024-03036-5. https://pubmed.ncbi.nlm.nih.gov/38641672/
5. Malone, Clare F, Mabe, Nathaniel W, Forman, Alexandra B, Dent, Sharon Y R, Stegmaier, Kimberly. 2024. The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma. In Science advances, 10, eadm9449. doi:10.1126/sciadv.adm9449. https://pubmed.ncbi.nlm.nih.gov/38820154/
6. Zhou, Xue, Wang, Ning, Zhang, Yuefeng, Yu, Hongzhi, Wu, Qi. 2021. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer. In Investigational new drugs, 40, 43-57. doi:10.1007/s10637-021-01159-6. https://pubmed.ncbi.nlm.nih.gov/34499335/
智鼠故事 
